Sensitivity to Interferon-Alpha and Interferon-Stimulated Gene Factor 3 Binding Activity in Human Chronic Myelogenous Leukemia Cell Line KT-1

Publisher： Karger

E-ISSN： 1421-9662|104|1|1-9

ISSN： 0001-5792

Source： Acta Haematologica, Vol.104, Iss.1, 2000-11, pp. : 1-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acral Sclerosis due to Interferon-Alpha-2b in Chronic Myelogenous Leukemia

By  

Acta Haematologica, Vol. 107, Iss. 1, 2002-01 ,pp. : 43-45

Karger

Access to resources Recommend Favorite

Thrombotic Thrombocytopenic Purpura during Interferon Alpha Treatment for Chronic Myelogenous Leukemia

By  

Acta Haematologica, Vol. 102, Iss. 3, 2004-11 ,pp. : 160-162

Karger

Access to resources Recommend Favorite

The relationships between IFNL4 genotype, intrahepatic interferon‐stimulated gene expression and interferon treatment response differs in HCV‐1 compared with HCV‐3

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 3, 2015-08 ,pp. : 296-306

John Wiley & Sons Inc

Access to resources Recommend Favorite

Elevated interferon‐stimulated gene transcription in peripheral blood mononuclear cells occurs in patients infected with genotype 1 but not genotype 3 hepatitis C virus

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 4, 2015-04 ,pp. : 384-390

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intrahepatic interferon‐stimulated gene responses: Can they predict treatment responses in chronic hepatitis C infection?

By  

HEPATOLOGY, Vol. 46, Iss. 5, 2007-11 ,pp. : 1326-1328

John Wiley & Sons Inc

Access to resources Recommend Favorite